Freedom Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,718
Closed -$1.05M 942
2021
Q2
$1.05M Sell
5,718
-497
-8% -$91.4K 0.08% 317
2021
Q1
$950K Sell
6,215
-3,709
-37% -$567K 0.07% 316
2020
Q4
$1.55M Sell
9,924
-577
-5% -$90.1K 0.17% 127
2020
Q3
$1.2M Sell
10,501
-701
-6% -$80.2K 0.13% 154
2020
Q2
$1.26M Sell
11,202
-2,451
-18% -$275K 0.14% 141
2020
Q1
$1.37M Buy
13,653
+419
+3% +$42.1K 0.12% 159
2019
Q4
$1.43M Sell
13,234
-1,637
-11% -$177K 0.13% 162
2019
Q3
$1.46M Sell
14,871
-2,861
-16% -$280K 0.13% 160
2019
Q2
$2.32M Sell
17,732
-1,005
-5% -$132K 0.19% 112
2019
Q1
$2.53M Buy
18,737
+103
+0.6% +$13.9K 0.2% 100
2018
Q4
$1.81M Sell
18,634
-1,396
-7% -$136K 0.14% 140
2018
Q3
$2.39M Sell
20,030
-782
-4% -$93.2K 0.15% 127
2018
Q2
$2.58M Buy
20,812
+14,056
+208% +$1.75M 0.16% 113
2018
Q1
$753K Buy
6,756
+125
+2% +$13.9K 0.04% 462
2017
Q4
$793K Buy
6,631
+170
+3% +$20.3K 0.04% 464
2017
Q3
$906K Sell
6,461
-315
-5% -$44.2K 0.05% 370
2017
Q2
$824K Buy
6,776
+38
+0.6% +$4.62K 0.05% 387
2017
Q1
$817K Sell
6,738
-781
-10% -$94.7K 0.05% 365
2016
Q4
$920K Sell
7,519
-1,919
-20% -$235K 0.06% 268
2016
Q3
$1.16M Sell
9,438
-289
-3% -$35.4K 0.07% 202
2016
Q2
$1.14M Buy
9,727
+400
+4% +$46.7K 0.08% 189
2016
Q1
$1.3M Sell
9,327
-647
-6% -$90K 0.09% 160
2015
Q4
$1.9M Sell
9,974
-10,740
-52% -$2.05M 0.14% 91
2015
Q3
$102K Buy
20,714
+14,164
+216% +$69.7K 0.01% 656
2015
Q2
$1.18M Buy
6,550
+1,856
+40% +$335K 0.12% 127
2015
Q1
$814K Buy
4,694
+2,334
+99% +$405K 0.09% 181
2014
Q4
$437K Buy
+2,360
New +$437K 0.06% 317